A structured index of tech-law analyses, DPDP compliance reviews, and legal governance guidelines.
We are bribing our AIs. We have built the most powerful technology in human history on a foundation of do this, get reward. Do that, get punished. And we have dressed it up in mathematics so elegant that we forgot to ask whether the underlying logic is as clean as the equations suggest. We call it "reinforcement learning." We call it "feedback training." We call it "alignment through human preference optimization." But strip away the technical language, squint at what's actually happening and a much more familiar picture emerges, one that looks less like education and a lot more like sliding an envelope across a table.
Instagram ends end-to-end encrypted chats on May 8, 2026. If you're a cybercrime victim, this change could affect your evidence, safety, and privacy and here's exactly what to do now.
Digital forensic investigation recovers deleted files, traces hacked accounts, and builds court-admissible evidence under India's new BNS, BNSS, and BSA 2023. Here is how it all works.
Singapore's Ministry of Law published a 50-page Gen AI guide for legal professionals on March 6, 2026. Here is what it says and what Indian advocates need to act on now.
A class action lawsuit filed March 4, 2026 accuses Meta of false advertising on its Ray-Ban AI glasses. Over 7 million pairs sold. Intimate footage routed to Kenya. Here is what it means legally for Indian consumers and AI device makers.
As Indian courts ban AI tools and the Supreme Court cites hallucinated cases, this commentary (written from the perspective of AI itself) makes the case for regulated, responsible AI use in Indian law. A framework for the bar and bench.
On March 20, 2026, the patent on semaglutide expired in India. Within 24 hours, at least five domestic drugmakers had launched generic versions of Novo Nordisk's Ozempic and Wegovy at prices up to 80% lower than the original. Sun Pharmaceutical launched its version for as low as Rs 750 for a weekly injection. Dr. Reddy's announced a target of 87 countries for generic semaglutide launches. The GLP-1 drug war in India had officially begun. But the more important story here is not about the drugs. It is about the law.
Select a core coordinate tag below to narrow down the legal treatises index.
Speak directly with our specialized team to structure corporate AI models, data systems, and policy guidelines.